Identification, cloning, and functional characterization of EmrD-3, a putative multidrug efflux pump of the major facilitator superfamily from Vibrio cholerae O395

Archives of Microbiology

Volumn 191, Issue 12, 2009, Pages 903-911

  Smith, Kenneth P ^a   Kumar, Sanath ^a   Varela, Manuel F ^a  

^a EASTERN NEW MEXICO UNIVERSITY   (United States)

Author keywords

Antimicrobial resistance; Efflux; EmrD 3; Linezolid; MIC; Vibrio cholerae

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; CFLA PROTEIN; CHLORAMPHENICOL; DNA; DYE; ERYTHROMYCIN; ETHIDIUM; ETHIDIUM BROMIDE; LINEZOLID; MEMBRANE PROTEIN; MINOCYCLINE; RHODAMINE 6G; RIFAMPICIN; TETRAPHENYLPHOSPHONIUM; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; CELL LEVEL; DNA BINDING; EMRD 3 GENE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE; GENE IDENTIFICATION; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FAMILY; RECOMBINANT PLASMID; SEQUENCE HOMOLOGY; VIBRIO CHOLERAE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARRIER PROTEINS; CLONING, MOLECULAR; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ETHIDIUM; FLUORESCENT DYES; GENE EXPRESSION REGULATION, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHYLOGENY; VIBRIO CHOLERAE;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; POSIBACTERIA; VIBRIO; VIBRIO CHOLERAE;

EID: 71449090136     PISSN: 03028933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00203-009-0521-8     Document Type: Article

References (53)

1. SF Altschul TL Madden AA Schaffer J Zhang Z Zhang W Miller DJ Lipman 1997 Gapped BLAST and PSI-BLAST: a new generation of protein database search programs Nucleic Acids Res 25 3389 3402 10.1093/nar/25.17.3389 1:CAS:528:DyaK2sXlvFyhu7w%3D 9254694 (Pubitemid 27359211)
2. Ausubel FM, Brent R, Kingsten RE, Moore DD, Seidman JG, Smith JA, Struhl K (1995) Short protocols in molecular biology, 3rd edn. Wiley, New York
3. A Begum MM Rahman W Ogawa T Mizushima T Kuroda T Tsuchiya 2005 Gene cloning and characterization of four MATE family multidrug efflux pumps from Vibrio cholerae non-O1 Microbiol Immunol 49 949 957 1:CAS:528:DC%2BD2MXhtlektbjJ 16301805
4. XR Bina D Provenzano N Nguyen JE Bina 2008 Vibrio cholerae RND family efflux systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine Infect Immun 76 3595 3605 10.1128/IAI.01620-07 1:CAS:528:DC%2BD1cXptF2iur0%3D 18490456
5. JA Bohnert WV Kern 2005 Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps Antimicrob Agents Chemother 49 849 852 10.1128/AAC.49.2.849-852.2005 1:CAS:528:DC%2BD2MXht12msr0%3D 15673787 (Pubitemid 40175716)
6. Buysse JM, Demyan WF, Dunyak DS, Stapert D, Hamel JC, Ford CW (1996) Mutation of the AcrAB antibiotic efflux pump in Escherichia coli confers susceptibility to oxazolidinone antibiotics [abstract C42] In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans).Washington, DC. American Society for Microbiology, 41
7. Clinical and Laboratory Standards Institute (CLSI) (2006) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard-seventh edition CLSI document M7-A7, Vol 26, No. 2
8. A Dalsgaard A Forslund A Petersen DJ Brown F Dias S Monteiro K Molbak P Aaby A Rodrigues A Sandström 2000 Class 1 integron-borne, multiple-antibiotic resistance encoded by a 150-kilobase conjugative plasmid in epidemic Vibrio cholerae O1 strains isolated in Guinea-Bissau J Clin Microbiol 38 3774 3779 1:CAS:528:DC%2BD3cXnsF2ms74%3D 11015401
9. R Edgar E Bibi 1997 MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition J Bacteriol 179 2274 2280 1:CAS:528:DyaK2sXit1CqsLw%3D 9079913
10. SM Faruque MJ Albert JJ Mekalanos 1998 Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae Microbiol Mol Biol Rev 62 1092 2172
11. J Feng A Lupien H Gingras J Wasserscheid K Dewar D Légaré M Ouellette 2009 Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance Genome Res 19 1214 1223 10.1101/gr.089342.108 1:CAS:528:DC%2BD1MXosVCktLY%3D 19351617
12. SL Ginn MH Brown RA Skurray 2000 The TetA(K) tetracycline/H(+) antiporter from Staphylococcus aureus: mutagenesis and functional analysis of motif C J Bacteriol 82 1492 1498 10.1128/JB.182.6.1492-1498.2000 (Pubitemid 30121111)
13. RD Gonzales PC Schreckenberger MB Graham S Kelkar K DenBesten JP Quinn 2001 Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid Lancet 357 1179 10.1016/S0140-6736(00)04376-2 1:CAS:528: DC%2BD3MXivFaqsb0%3D 11323048 (Pubitemid 32378693)
14. JK Griffith ME Baker DA Rouch MGP Page RA Skurray IT Paulsen KF Chater SA Baldwin PJF Henderson 1992 Membrane transport proteins: implications of sequence comparisons Curr Opin Cell Biol 4 684 695 10.1016/0955-0674(92)90090-Y 1:CAS:528:DyaK38XlvVKrurs%3D 1419050
15. S Grkovic MH Brown RA Skurray 2002 Regulation of bacterial drug export systems Microbiol Mol Biol Rev 66 671 701 10.1128/MMBR.66.4.671-701.2002 1:CAS:528:DC%2BD38XpslemtLo%3D 12456787 (Pubitemid 35425113)
16. JD Hayes CR Wolf 1990 Molecular mechanisms of drug resistance Biochem J 272 281 295 1:CAS:528:DyaK3cXmt1OlsLw%3D 1980062
17. CF Higgins 2007 Multiple molecular mechanisms for multidrug resistance transporters Nature 446 749 757 10.1038/nature05630 1:CAS:528: DC%2BD2sXktVeqsbk%3D 17429392 (Pubitemid 46582024)
18. D Higgins J Thompson T Gibson JD Thompson DG Higgins TJ Gibson 1994 CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucleic Acids Res 22 4673 4680 10.1093/nar/22.22.4673 7984417
19. T Hirai A Jurgen W Heymann PC Maloney S Subramaniam 2003 Structural model for 12-helix transporters belonging to the major facilitator superfamily J Bacteriol 185 1712 1718 10.1128/JB.185.5.1712-1718.2003 1:CAS:528: DC%2BD3sXhs1Sisbw%3D 12591890 (Pubitemid 36245974)
20. T Hirata A Saito K Nishino N Tamura A Yamaguchi 2004 Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936) Antimicrob Agents Chemother 48 2179 2184 10.1128/AAC.48.6.2179-2184.2004 1:CAS:528:DC%2BD2cXks1yqtLk%3D 15155219 (Pubitemid 38691616)
21. + antiporters: characterization of multiple catalytic modes and a mutagenesis approach to differences in their efflux substrate and coupling ion preferences J Bacteriol 184 4722 4732 10.1128/JB.184.17.4722-4732.2002 1:CAS:528:DC%2BD38Xmt12gu78%3D 12169596 (Pubitemid 34898259)
22. PA Krieg DA Melton 1987 In vitro RNA synthesis with SP6 RNA polymerase Methods Enzymol 155 97 415
23. CJ Law PC Maloney D Wang 2008 Ins and outs of major facilitator superfamily antiporters Ann Rev Microbiol 62 289 305 10.1146/annurev.micro.61. 080706.093329 1:CAS:528:DC%2BD1cXht1Gls73O
24. K Lewis 1994 Multidrug resistance pumps in bacteria: variations on a theme Trends Biochem Sci 19 119 123 10.1016/0968-0004(94)90204-6 1:CAS:528:DyaK2cXktVCmt7s%3D 8203018 (Pubitemid 24082789)
25. MC Maiden EO Davis SA Baldwin DC Moore PJ Henderson 1987 Mammalian and bacterial sugar transport proteins are homologous Nature 325 641 643 10.1038/325641a0 1:CAS:528:DyaL2sXhslWnsLg%3D 3543693 (Pubitemid 17055690)
26. L McMurry AM George SB Levy 1994 Active efflux of chloramphenicol in susceptible Escherichia coli strains and in multiple-antibiotic-resistant (Mar) mutants Antimicrob Agents Chemother 38 542 546 1:CAS:528:DyaK2cXitFans7g%3D 8203852
27. VG Meka SK Pillai G Sakoulas C Wennersten L Venkataraman PC DeGirolami GM Eliopoulos RC Moellering Jr HS Gold 2004 Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA J Infect Dis 190 311 317 10.1086/421471 1:CAS:528:DC%2BD2cXmsFaqtLs%3D 15216466 (Pubitemid 38951971)
28. Y Minato F Shahcheraghi W Ogawa T Kuroda T Tsuchiya 2008 Functional gene cloning and characterization of the SsmE multidrug efflux pump from Serratia marcescens Biol Pharm Bull 31 516 519 10.1248/bpb.31.516 1:CAS:528: DC%2BD1cXmtlaktLk%3D 18310921
29. T Mine Y Morita A Kataoka T Mizushima T Tsuchiya 1998 Evidence for chloramphenicol/H+ antiport in Cmr (MdfA) system of Escherichia coli and properties of the antiporter J Biochem 124 187 193 1:CAS:528:DyaK1cXmslyku7s%3D 9644262
30. T Mine Y Morita A Kataoka T Mizushima T Tsuchiya 1999 Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa Antimicrob Agents Chemother 43 415 417 1:CAS:528:DyaK1MXpvFKisg%3D%3D 9925549
31. MAS Moreira EC Souza CA Moraes 2004 Multidrug efflux systems in gram-negative bacteria Braz J Microbiol 35 19 28 10.1590/S1517-83822004000100003 1:CAS:528:DC%2BD28XntVyrsbg%3D
32. AH Mutnick V Enne RN Jones 2003 Linezolid resistance since 2001: SENTRY antimicrobial surveillance program Ann Pharmacother 37 769 774 10.1345/aph.1C437 1:CAS:528:DC%2BD3sXkslemsbs%3D 12773059 (Pubitemid 36618358)
33. JC Mwansa J Mwaba C Lukwesa NA Bhuiyan M Ansaruzzaman T Ramamurthy M Alam G Balakrish Nair 2007 Multiply antibiotic-resistant Vibrio cholerae O1 biotype El Tor strains emerge during cholera outbreaks in Zambia Epidemiol Infect 135 847 853 10.1017/S0950268806007254 1:CAS:528:DC%2BD2sXnsFyltLk%3D 17121691 (Pubitemid 47161670)
34. H Okuso D Ma H Nikaido 1996 AcrAB efflux plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic- resistance (Mar) mutants J Bacteriol 178 306 308
35. M Otsuka M Yasuda Y Morita C Otsuka T Tsuchiya H Omote Y Moriyama 2005 Identification of essential amino acid residues of the NorM Na +/multidrug antiporter in Vibrio parahaemolyticus J Bacteriol 187 1552 1558 10.1128/JB.187.5.1552-1558.2005 1:CAS:528:DC%2BD2MXhvFKmt7o%3D 15716425 (Pubitemid 40289355)
36. + circulation in cells Biochim Biophys Acta 1187 206 210 10.1016/0005-2728(94)90112-0 1:CAS:528:DyaK2cXmt1Cgtrg%3D 8075114 (Pubitemid 24267056)
37. SS Pao IT Paulsen MH Saier 1998 Major facilitator superfamily Microbiol Mol Biol Rev 62 1 34 1:CAS:528:DyaK1cXitF2jsLg%3D 9529885
38. + transport Eukaryot Cell 6 443 453 10.1128/EC.00315-06 1:CAS:528:DC%2BD2sXjsFCit7k%3D 17209122 (Pubitemid 46492332)
39. M Putman HW van Veen WN Konings 2000 Molecular properties of bacterial multidrug transporters Microbiol Mol Biol Rev 64 672 693 10.1128/MMBR.64.4.672- 693.2000 1:CAS:528:DC%2BD3MXltFWjtrw%3D 11104814 (Pubitemid 32475926)
40. MM Rahman T Matsuo W Ogawa M Koterasawa T Kuroda T Tsuchiya 2007 Molecular cloning and characterization of all RND-type efflux transporters in Vibrio cholerae non-O1 Microbiol Immunol 51 1061 1070 1:CAS:528: DC%2BD1cXhsVWnu74%3D 18037783
41. CM Roberts 2008 Update on macrolide-lincosamide-streptogramin, ketolide and oxazolidinone resistance genes FEMS Microbiol Lett 282 147 159 10.1111/j.1574-6968.2008.01145.x 1:CAS:528:DC%2BD1cXmsFOisbo%3D 18399991 (Pubitemid 351569469)
42. EJ Rubin W Lin JJ Mekalanos MK Waldor 1998 Replication and integration of a Vibrio cholerae cryptic plasmid linked to the CTX prophage Mol Microbiol 28 1247 1254 10.1046/j.1365-2958.1998.00889.x 1:CAS:528:DyaK1cXktl2isLY%3D 9680213 (Pubitemid 28293547)
43. P Sander L Belova YG Kidan P Pfister AS Mankin EC Böttger 2002 Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations Mol Microbiol 46 1295 1304 10.1046/j.1365-2958.2002.03242.x 1:CAS:528:DC%2BD38XpsFGisLg%3D 12453216 (Pubitemid 36961264)
44. 14C linezolid to healthy human subjects Drug Metab Dispos 29 1136 1145 1:CAS:528:DC%2BD3MXlsVChtb8%3D 11454733
45. SM Swaney H Aoki MC Ganoza DL Shinabarger 1998 The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria Antimicrob Agents Chemother 42 3251 3255 1:CAS:528:DyaK1cXnvFOqt7c%3D 9835522
46. S Tsiodras HS Gold G Sakoulas GM Eliopoulos C Wennersten L Venkataraman RC Moellering MJ Ferraro 2001 Linezolid resistance in a clinical isolate of Staphylococcus aureus Lancet 358 207 208 10.1016/S0140-6736(01)05410-1 1:CAS:528:DC%2BD3MXltlymsr8%3D 11476839 (Pubitemid 32718546)
47. HW Van Veen WN Konings 1998 Structure and function of multidrug transporters Adv Exp Med Biol 456 145 158 10549367
48. MF Varela TH Wilson 1996 Molecular biology of the lactose carrier of Escherichia coli Biochim Biophys Acta 1276 21 34 10.1016/0005-2728(96)00030-8 8764889 (Pubitemid 26254995)
49. MF Varela CE Sansom JK Griffith 1995 Mutational analysis and molecular modelling of an amino acid sequence motif conserved in antiporters but not symporters in a transporter superfamily Mol Membr Biol 12 313 319 10.3109/09687689509072433 1:CAS:528:DyaK28Xht1OrtA%3D%3D 8747276
50. RC Woolley G Vediyappan M Anderson M Lackey B Ramasubramanian B Jiangping T Borisova JA Colmer AN Hamood CS McVay JA Fralick 2005 Characterization of the Vibrio cholerae vceCAB multiple-drug resistance efflux operon in Escherichia coli J Bacteriol 187 5500 5503 10.1128/JB.187.15.5500-5503.2005 1:CAS:528:DC%2BD2MXmslCrt78%3D 16030246 (Pubitemid 41022970)
51. L Xiong P Kloss S Douthwaite NM Andersen S Swaney DL Shinabarger AS Mankin 2000 Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action J Bacteriol 182 5325 5331 10.1128/JB.182.19.5325-5331.2000 1:CAS:528: DC%2BD3cXmvVyrsrY%3D 10986233 (Pubitemid 30737378)
52. P Zhong VD Shortridge 2000 The role of efflux in macrolide resistance Drug Resist Updates 3 325 329 10.1054/drup.2000.0175 1:CAS:528: DC%2BD3MXht1Wltrk%3D (Pubitemid 32118398)
53. GE Zurenko BH Yagi RD Schaadt JW Allison JO Kilburn SE Glickman DK Hutchinson MR Barbachyn SJ Brickner 1996 In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents Antimicrob Agents Chemother 40 839 845 1:CAS:528:DyaK28XitVWqs74%3D 8849237